drugset / Trial / NCT01827579
Infusion of Depleted T Cells Following Unrelated Donor Stem Cell Transplant (ICAT)
RandomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to evaluate whether the administration of allodepleted donor T cells to patients with haematological malignancies after stem cell transplant can improve the recovery of the patients immune system.
Timeline
- Start
- 2014-07
- Primary completion
- 2020-01
- Completion
- 2020-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CD25/71 allodepleted donor T-cells | Cell therapy | 1e+06 cells/kg | — |